Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111484962B enables efficient 5α-AD production via engineered Mycobacterium. Discover cost reduction in steroid manufacturing and reliable supply chain solutions.
Patent CN106119272A reveals efficient enzymatic co-production reducing cofactor costs for pharmaceutical intermediate manufacturing supply chains and enhancing scalability.
Patent CN106755254B details a mild enzymatic route for lipoic acid sterol ester, offering high purity and yield for food and pharma applications.
Patent CN108546691A details a novel 7β-HSDH mutant using NADH for cost-effective ursodeoxycholic acid production with high purity and yield.
Novel enzymatic resolution and atmospheric coupling process for high-purity pharmaceutical intermediates ensuring cost reduction and supply reliability.
Patent CN114634944A details a novel co-expression vector method for Atorvastatin intermediates, offering significant cost reduction and enhanced supply chain reliability for pharmaceutical manufacturers.
Patent CN117025699A reveals a chemo-enzymatic route for Larotinib intermediates. Achieve high ee values and reduced costs with scalable pharmaceutical manufacturing solutions.
Patent CN118791350B reveals enzymatic synthesis of novel antibacterial diterpenoids. Offers green manufacturing and supply chain reliability for pharmaceutical intermediates.
Patent CN102277322A details a green enzymatic route for IDA production, offering lower costs and reduced waste compared to traditional chemical hydrolysis methods.
Patent CN103290078B reveals purified enzyme catalysis for 5-aminovaleric acid production offering simplified separation and high yield for scalable polymer intermediate manufacturing supply chains.
Patent CN101547893B reveals a novel salt recovery method for biphenylalanine, enabling cost reduction in pharmaceutical intermediate manufacturing through direct extraction and recycling.
Patent CN113667704B reveals a green two-step enzymatic route for high-purity (R)-DMPM. This method offers significant cost reduction and supply chain reliability for agrochemical manufacturers.
Novel enzymatic method for L-carnosine offers high purity and yield. Reduces cost and environmental impact for pharmaceutical manufacturing supply chains globally.
Patent CN120796399A reveals a high-yield enzymatic route for this chiral intermediate. Discover cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN1100144A details enzymatic resolution for high-purity taxane intermediates, offering cost-effective and scalable pharmaceutical manufacturing solutions.
Discover the environmentally friendly synthesis of chiral 2,3-alkenols using lipase catalysis. A breakthrough in pharmaceutical intermediate manufacturing offering high purity and cost efficiency.
Novel enzymatic route for S-indoline-2-carboxylic acid ensures >99% ee purity and simplified processing for reliable pharmaceutical intermediate supply chains.
Patent CN105420285B reveals a scalable enzymatic method for producing optically active heptadecene compounds, offering significant cost reduction and supply chain reliability for agrochemical manufacturers.
Novel ADH mutant enables high-purity Brivaracetam intermediate production with superior stereoselectivity and cost-effective supply chain solutions.
Novel enzymatic route for dabigatran intermediate offers high purity and cost efficiency for pharmaceutical manufacturing supply chains globally ensuring reliable production capacity.